dextromethorphan/quinidine
Sign in to saveAlso known as dextromethorphan / quinidine
Dextromethorphan/quinidine, sold under the brand name Nuedexta, is a fixed-dose combination medication for the treatment of pseudobulbar affect (PBA). It contains dextromethorphan (DXM) and the class I antiarrhythmic agent quinidine.
Medication
- Brand names
- Nuedexta
- Drug class
- Opium alkaloids and derivatives, Antiarrhythmics, class Ia
- Active ingredients
- dextromethorphan, quinidine, dextromethorphan / quinidine
- Dosage form
- Oral Capsule
Clinical Trials
28 registered- PHASE3COMPLETEDSafety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis PatientsAvanir Pharmaceuticals · NCT00050232
- PHASE3COMPLETEDSafety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALSAvanir Pharmaceuticals · NCT00021697
- PHASE1COMPLETEDA Phase 1 Study Comparing AVP-786 With AVP-923Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT02336347
- PHASE4TERMINATEDNuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's DiseaseSt. Joseph's Hospital and Medical Center, Phoenix · NCT01832350
- PHASE2COMPLETEDSafety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisAvanir Pharmaceuticals · NCT01324232
- PHASE3COMPLETEDSafety and Efficacy of AVP-923 in PBA Patients With ALS or MSAvanir Pharmaceuticals · NCT00573443
Wikidata facts
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
10 sectionsContents
- Medical uses
- Contraindications
- Adverse effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Research
- See also
- References
- External links
Dextromethorphan/quinidine, sold under the brand name Nuedexta, is a fixed-dose combination medication for the treatment of pseudobulbar affect (PBA). It contains dextromethorphan (DXM) and the class I antiarrhythmic agent quinidine.
Dextromethorphan/quinidine was approved for medical use in the United States in October 2010, and is marketed by Avanir Pharmaceuticals.
Excerpted from Wikipedia’s “dextromethorphan/quinidine” article, available under the CC BY-SA 4.0 licence.